More medical researchers are questioning the standard one-disease-at-a-time approach that has dominated the search for cures to aging-related illnesses such as cancer, heart disease, diabetes, Alzheimer’s, and Parkinson’s. On November 21st, Brandon Keim reported, on the Wired Science blog, that researchers frustrated with the limited success of the narrower conventional approach are opening up to the idea of using mitochondrial medicine. The aim is to ward off the diseases caused by aging by addressing their shared sources, repairing and preventing the damage caused by the free oxygen radicals released as the mitochondria degenerate and break down.

A number of new anti-aging drugs are in development and could be on the market within the next five years

Resveratrol, probably the best known of the mitochondrial drugs (it's that stuff in red wine), is currently in clinical human trials for diabetes